 |
|
Diagnosis and treatment of patients with IgA nephropathy in Japan
Yasuhiko Tomino
Kidney Res Clin Pract. 2016;35(4):197-203. Published online 2016 Sep 15 DOI: https://doi.org/10.1016/j.krcp.2016.09.001
|
|
Citations to this article as recorded by
 Pneumocystis pneumonia following surgery for left-sided tongue cancer: A case study
Shinichi Sato, Masato Takahashi
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2024; 36(2): 230. CrossRef Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy
Mengying Sun, Guojuan Shi, Xiaohan Zhang, Chao Kan, Shimin Xie, Weixiang Peng, Wenjun Liu, Peter Wang, Rui Zhang
Aging.2024;[Epub] CrossRef An enhanced machine learning approach for effective prediction of IgA nephropathy patients with severe proteinuria based on clinical data
Yaozhe Ying, Luhui Wang, Shuqing Ma, Yun Zhu, Simin Ye, Nan Jiang, Zongyuan Zhao, Chenfei Zheng, Yangping Shentu, YunTing Wang, Duo Li, Ji Zhang, Chaosheng Chen, Liyao Huang, Deshu Yang, Ying Zhou
Computers in Biology and Medicine.2024; 173: 108341. CrossRef Identification of key genes for IgA nephropathy based on machine learning algorithm and correlation analysis of immune cells
Suzhi Chen, Yongzhang Li, Guangjian Wang, Lei Song, Jinchuan Tan, Fengwen Yang
Transplant Immunology.2023; 78: 101824. CrossRef Glomerular expression and urinary excretion of fatty acid-binding protein 4 in IgA nephropathy
Marenao Tanaka, Norihito Moniwa, Chieko Nogi, Toshiki Kano, Megumi Matsumoto, Akiko Sakai, Takuto Maeda, Hideki Takizawa, Yayoi Ogawa, Katsuhiko Asanuma, Yusuke Suzuki, Masato Furuhashi
Journal of Nephrology.2023; 36(2): 385. CrossRef miR-148b as a Potential Biomarker for IgA Nephropathy
Santosh Kumar, C. Priscilla, Sreejith Parameswaran, Deepak Gopal Shewade, Pragasam Viswanathan, Rajesh Nachiappa Ganesh
Kidney and Dialysis.2023; 3(1): 84. CrossRef Seasonal variations in renal biopsy numbers and primary glomerular disease features based on the Japan renal biopsy registry
Go Kanzaki, Nobuo Tsuboi, Takashi Yokoo, Noriko Uesugi, Kengo Furuichi, Akira Shimizu, Hitoshi Sugiyama, Hiroshi Sato, Hitoshi Yokoyama, Hiroshi Sato, Akira Shimizu, Hitoshi Sugiyama, Hiroshi Kitamura, Ritsuko Katafuchi, Shinichi Nishi, Motoshi Hattori, R
Scientific Reports.2023;[Epub] CrossRef Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study
Yan Li, Qi Wan, Zhixin Lan, Ming Xia, Haiyang Liu, Guochun Chen, Liyu He, Chang Wang, Hong Liu
PeerJ.2022; 10: e14481. CrossRef Computational Pipeline for Glomerular Segmentation and Association of the Quantified Regions with Prognosis of Kidney Function in IgA Nephropathy
Yoshimasa Kawazoe, Kiminori Shimamoto, Ryohei Yamaguchi, Issei Nakamura, Kota Yoneda, Emiko Shinohara, Yukako Shintani-Domoto, Tetsuo Ushiku, Tatsuo Tsukamoto, Kazuhiko Ohe
Diagnostics.2022; 12(12): 2955. CrossRef Dysbiosis in the Salivary Microbiome Associated with IgA Nephropathy—A Japanese Cohort Study
Anushka Khasnobish, Lena Takayasu, Ken-ichi Watanabe, Tien Thi Thuy Nguyen, Kensuke Arakawa, Osamu Hotta, Kensuke Joh, Akiyo Nakano, Shuhei Hosomi, Masahira Hattori, Wataru Suda, Hidetoshi Morita
Microbes and Environments.2021; 36(2): n/a. CrossRef Nature and frequency of diagnosis of different forms of glomerulonephritis as cause of development and progression of chronic kidney disease in different world regions according to clinical and morphological studies with renal biopsy
E. M. Evsikov, N. V. Teplova, N. G. Artamonova, G. A. Chervyakova, V. I. Vechorko
Medical alphabet.2021; (17): 43. CrossRef Risk factors for progression IgA-nephropathy in children
M. V. Proskura, E. K. Petrosyan, P. E. Povilaitite, B. L. Kushnir
Nephrology (Saint-Petersburg).2021; 25(4): 48. CrossRef Age-adjusted global glomerulosclerosis predicts renal progression more accurately in patients with IgA nephropathy
Chan-Sung Chung, Ji-Hye Lee, Si-Hyong Jang, Nam-Jun Cho, Wook-Joon Kim, Nam Hun Heo, Hyo-Wook Gil, Eun Young Lee, Jong-Seok Moon, Samel Park
Scientific Reports.2020;[Epub] CrossRef A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy
Motonori Sugiyama, Yukihiro Wada, Nobuhiro Kanazawa, Shohei Tachibana, Taihei Suzuki, Kei Matsumoto, Masayuki Iyoda, Hirokazu Honda, Takanori Shibata, Fabio Sallustio
PLOS ONE.2020; 15(4): e0232194. CrossRef Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy
Ji-Hye Lee, Si-Hyong Jang, Nam-Jun Cho, Nam Hun Heo, Hyo-Wook Gil, Eun Young Lee, Jong-Seok Moon, Samel Park
Kidney Research and Clinical Practice.2020; 39(3): 295. CrossRef Modern approaches to pharmacotherapy of chronic glomerulonephritis
Vsevolod Skvortsov, Aleksandr Tumarenko, Georgiy Malyakin, Ellina Golieva
Spravočnik vrača obŝej praktiki (Journal of Family Medicine).2020; (8): 36. CrossRef Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy
Seohyun Park, Hyung Woo Kim, Jung Tak Park, Tae Ik Chang, Ea Wha Kang, Dong-Ryeol Ryu, Tae-Hyun Yoo, Ho Jun Chin, Hyeon Joo Jeong, Shin-Wook Kang, Beom Jin Lim, Seung Hyeok Han
Nephrology Dialysis Transplantation.2020; 35(12): 2130. CrossRef Complement activation is associated with crescent formation in IgA nephropathy
Hiroe Itami, Shigeo Hara, Kenichi Samejima, Hideo Tsushima, Katsuhiko Morimoto, Keisuke Okamoto, Takaaki Kosugi, Takahiro Kawano, Kengo Fujiki, Hiromichi Kitada, Kinta Hatakeyama, Kazuhiko Tsuruya, Chiho Ohbayashi
Virchows Archiv.2020; 477(4): 565. CrossRef Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers
Amir Taherkhani, Reyhaneh Farrokhi Yekta, Maede Mohseni, Massoud Saidijam, Afsaneh Arefi Oskouie
Proteome Science.2019;[Epub] CrossRef Successful Use of Aliskiren in a Case of IgA- Mesangial Glomerulonephritis Unresponsive to Conventional Therapies
Mariadelina Simeoni, Ramona Nicotera, Elena Pelagi, Emanuela Libri, Nicolino Comi, Giorgio Fuiano
Reviews on Recent Clinical Trials.2019; 14(1): 72. CrossRef The gut–kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition
Rosanna Coppo
Pediatric Nephrology.2018; 33(1): 53. CrossRef Treatment of IgA Nephropathy: Evolution Over Half a Century
Jonathan Barratt, Sydney C.W. Tang
Seminars in Nephrology.2018; 38(5): 531. CrossRef Urinary Exosome-Derived microRNAs Reflecting the Changes in Renal Function in Cats
Osamu Ichii, Hiroshi Ohta, Taro Horino, Teppei Nakamura, Marina Hosotani, Tatsuya Mizoguchi, Keitaro Morishita, Kensuke Nakamura, Noboru Sasaki, Mitsuyoshi Takiguchi, Ryo Sato, Kazuhisa Oyamada, Yaser Hosny Ali Elewa, Yasuhiro Kon
Frontiers in Veterinary Science.2018;[Epub] CrossRef The Gut-Renal Connection in IgA Nephropathy
Rosanna Coppo
Seminars in Nephrology.2018; 38(5): 504. CrossRef Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study
Yusuke Okabayashi, Nobuo Tsuboi, Hoichi Amano, Yoichi Miyazaki, Tetsuya Kawamura, Makoto Ogura, Ichiei Narita, Toshiharu Ninomiya, Hitoshi Yokoyama, Takashi Yokoo
BMJ Open.2018; 8(10): e024317. CrossRef Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
Yukihiro Wada, Kei Matsumoto, Taihei Suzuki, Tomohiro Saito, Nobuhiro Kanazawa, Shohei Tachibana, Ken Iseri, Motonori Sugiyama, Masayuki Iyoda, Takanori Shibata, Ivan Cruz Moura
PLOS ONE.2018; 13(11): e0206865. CrossRef Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients
Kazuya Tsuboi, Hiroshi Yamamoto
BMC Pharmacology and Toxicology.2017;[Epub] CrossRef
|